19O A phase Ib trial of CFI-402257 in combination with weekly paclitaxel in patients with advanced HER2-negative (HER2-) breast cancer (aBC)
Titel:
19O A phase Ib trial of CFI-402257 in combination with weekly paclitaxel in patients with advanced HER2-negative (HER2-) breast cancer (aBC)
Auteur:
Bedard, P. Mates, M. Gelmon, K.A. Hilton, J. Tu, D. Li, I. Rastgou, L. Drummond-Ivars, N. Edwards, J. Warr, D. Lohrisch, C. Song, X. Srikanthan, A. Robinson, A. Hagerman, L. Seymour, L.K. Rushton, M. Cescon, D.W.